Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-25T05:18:51.255Z Has data issue: false hasContentIssue false

14 - Lifespan aspects of endocrine disorders

from Section II - Disorders

Published online by Cambridge University Press:  07 May 2010

Jacobus Donders
Affiliation:
Mary Free Bed Rehabilitation Hospital
Scott J. Hunter
Affiliation:
University of Chicago
Get access

Summary

Endocrine disorders across the lifespan

Endocrine disorders are a complex set of conditions resulting in abnormal hormonal release and regulation that can negatively impact growth and development, metabolism, and sexual functioning/reproduction. These disorders can arise at almost any point throughout the lifespan, from the prenatal period to old age. The effect of these conditions on the central nervous system may also vary from profound developmental disorders to subtle and possibly reversible cognitive impairments. In many cases, the mechanisms for cognitive and neurobehavioral effects of endocrine disorders are poorly understood.

Overview of the endocrine system

Table 14.1 presents the major anatomical structures of the endocrine system, their general function, and associated hormones. These structures regulate and release hormones in the body. The system is responsible for growth and development, reproduction, metabolism (energy production and storage), homeostasis, and responding to internal and external environmental changes. There are strong interactions between the endocrine, nervous, and immune systems. The pituitary gland and the hypothalamus are particularly important because they are involved in a feedback regulation of hormone production across the thyroid, adrenal, and gonadal axes. In general, a neural signal of imbalance in one of these endocrine systems leads to secretion of releasing factor from the hypothalamus, which triggers the pituitary gland to release a tropic hormone. The tropic hormone stimulates production and release of hormones from the specified endocrine gland. As a result, levels of circulating hormones normalize.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jones, JH, Mackenzie, J, Croft, GA, et al. Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979–2003. Arch Dis Child 2006;91:680–5.CrossRefGoogle ScholarPubMed
Hadley, M, Levine, JE. Endocrinology, 6th edn. Upper Saddle River, NJ: Prentice Hall; 2007.Google Scholar
Selva, KA, Harper, A, Downs, A, et al. Neurodevelopmental outcomes in congenital hypothyroidism: Comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005;147:775–80.CrossRefGoogle ScholarPubMed
Bongers-Schokking, JJ, Muinck Keizer-Schrama, SMPF. Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr 2005;147:768–74.CrossRefGoogle ScholarPubMed
Kempers, MJE, Sluijs Veer, L, Nijhuis-van der Sanden, RWG, et al. Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab 2006;91:418–24.CrossRefGoogle ScholarPubMed
Rovet, J, Hepworth, S. Attention problems in adolescents with congential hypothyroidism: A multicomponential analysis. J Int Neuropsychol Soc 2001;7:734–44.CrossRefGoogle Scholar
Alvarez, M, Guell, R, Chong, D, et al. Attention processing in hyperthyroid children before and after treatment. J Pediatr Endocrinol Metab 1996;9:447–54.CrossRefGoogle ScholarPubMed
Tunbridge, WMG, Evered, DC, Hall, R, et al. The spectrum of thyroid disease in the community: The Whickham Survey.Clin Endocrinol 1977;7:481–93.CrossRefGoogle ScholarPubMed
Whybrow, PC, Prange, AJ, Treadway, CR. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch Gen Psychiat 1969;20:48–63.CrossRefGoogle ScholarPubMed
Davis, JD, Tremont, G. Neuropsychatric aspects of hypothyroidism and treatment reversibility.Minerva Endocrinol 2007;32:49–65.Google Scholar
Ganguli, M, Burmeister, , Seaberg, EC, et al. Association between dementia and elevated TSH: a community-based study. Biol Psychiat 1996;40:714–25.CrossRefGoogle ScholarPubMed
Constant, EL, Volder, AG, Ivanoiu, A, et al. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metab 2001;86:3864–70.CrossRefGoogle ScholarPubMed
Smith, CD, Ain, KB. Brain metabolism in hypothyroidism studies with 31P magnetic-resonance spectroscopy. Lancet 1993;345:619–20.CrossRefGoogle Scholar
Zhu, D-F, Wang, Z-X, Zhang, D-R, et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 2006;129:2923–30.CrossRefGoogle ScholarPubMed
Piga, M, Serra, A, Deiana, L, et al. Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur J Nucl Med Mol I 2004;31:1639–44.CrossRefGoogle ScholarPubMed
Osterweil, D, Syndulko, K, Cohen, SN, et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992;40:325–35.CrossRefGoogle ScholarPubMed
Jorde, R, Waterloo, K, Storhaug, H, et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006;91:145–53.CrossRefGoogle ScholarPubMed
Clarnette, RM, Patterson, CJ. Hypothyroidism: Does treatment cure dementia? J Geriatr Psychiatry Neurol 1994;6:23–7.CrossRefGoogle Scholar
Haupt, M, Kurz, A. Reversibility of dementia in hypothyroidism. J Neurol 1993;240:333–5.CrossRefGoogle ScholarPubMed
Trzepacz, PT, McCue, M, Klein, I, Greenhouse, J, Levey, GS. Psychiatric and neuropsychological response to propanolol in Graves' disease. Biol Psychiat 1988;23:678–88.CrossRefGoogle ScholarPubMed
Fahrenfort, JJ, Wilterdink, AM, Veen, EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000;25:201–11.CrossRefGoogle ScholarPubMed
Vogel, A, Elberling, TV, Hording, M, Dock, J, et al. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology 2007;32:36–43.CrossRefGoogle ScholarPubMed
Bommer, M, Eversemann, T, Pickardt, R, et al. Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism. Klin Wochenschrift 1990;68:552–8.CrossRefGoogle ScholarPubMed
Bhatara, VS, Tripathi, RP, Sankar, R et al. Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. Psychoneuroendoncrinology 1998;23:605–12.CrossRefGoogle ScholarPubMed
Trivalle, C, Doucet, J, Chassagne, P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996;44:50–3.CrossRefGoogle ScholarPubMed
Fukui, T, Hasegawa, Y, Takenaka, H. Hyperthyroidism dementia: Clinicoradiological findings and response to treatment. J Neurol Sci 2001;184:81–8.CrossRefGoogle ScholarPubMed
Kalmijn, S, Mehta, KM, Pois, HA, et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol 2000;53:733–7.CrossRefGoogle ScholarPubMed
Mocellin, R, Walterfang, M, Velakoulis, D. Hashimoto's encephalopathy: epidemiology, pathogenesis, and management. CNS Drugs 2007;21:799–11.CrossRefGoogle ScholarPubMed
Chong, JY, Rowland, LP, Utiger, RD. Hashimoto encephalopathy: syndrome or myth. Arch Neurol 2003;60:164–71.CrossRefGoogle ScholarPubMed
Denko, J, Kaelbling, R. The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand 1962;164:1–70.Google Scholar
Coker, LH, Rorie, K, Cantley, L, et al. Primary hyperparathyroidism, cognition, and quality of life. Ann Surg 2005;242:642–50.CrossRefGoogle Scholar
Okamoto, T, Gerstein, HC, Obara, T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J 1997;44:367–74.CrossRefGoogle ScholarPubMed
Numann, PJ, Torppa, AJ, Blumetti, AE. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery 1984;96:1119–23.Google ScholarPubMed
Brown, GG, Preisman, RC, Kleerekoper, M. Neurobehavioral symptoms in mild primary hyperparathyroidism: Related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J 1987;35:211–15.Google Scholar
Mjaland, O, Normann, E, Halvorsen, E, et al. Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathyroidectomy. Br J Surg 2003;134:732–7.CrossRefGoogle Scholar
Perrier, ND, Coker, LH, Rorie, KD, et al. Preliminary Report: Functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg 2006;30:686–96.CrossRefGoogle ScholarPubMed
Heller, SR, Macdonald, IA. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 1996;13:607–15.3.0.CO;2-I>CrossRefGoogle Scholar
Cox, DJ, Kovatchev, BP, Gonder-Frederice, , et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005;28:71–7.CrossRefGoogle ScholarPubMed
Nold, J, Georgieff, MK. Infants of diabetic mothers. In Rademacher, R, Kliegman, R, eds. Pediatric Clinics of North America. Philadelphia, PA: WB Saunders; 2004: 619–37.Google Scholar
Miller, E, Hare, JW, Cloherty, JP, et al. Elevated maternal hemoglobin A1C in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304:1331–4.CrossRefGoogle ScholarPubMed
Mills, JL, Simpson, JL, Driscoll, SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988;319:1617–23.CrossRefGoogle ScholarPubMed
Boney, CM, Verma, A, Tucker, R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity and gestational diabetes mellitus. Pediatrics 2005;115:e290–6.CrossRefGoogle ScholarPubMed
Ornoy, A, Ratzon, N, Greenbaum, C, et al. School-age children born to diabetic mothers and to mothers with gestational diabetes exhibit a high rate of inattention and fine and gross motor impairment. J Pediatr Endocrinol Metab 2001;14 S1:681–9.CrossRefGoogle ScholarPubMed
Ornoy, A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev 2005;3:104–13.Google ScholarPubMed
Bruno, G, Runzo, C, Vavallo-Perin, P, et al. Incidence of type 1 and type 2 diabetes in adults aged 30–49 years: the population-based registry in province of Turin, Italy. Diabetes Care 2005;28:2613–19.CrossRefGoogle ScholarPubMed
Rosenbloom, AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990;13:22–33.CrossRefGoogle ScholarPubMed
The Diabetes Control and Complications Trial: Effects of intensive diabetes therapy on neuropsychological function in adults in the diabetes control and complications trial. Ann Intern Med 1996;124:379–88.CrossRef
Ryan, C, Becker, D. Hypoglycemia in children with type 1 diabetes mellitus: risk factors, cognitive function, and management. Endocrinol Metab Clin North Am 1999;28:883–900.CrossRefGoogle ScholarPubMed
Northam, EA, Anderson, PJ, Jacobs, R, et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001;24:1541–6.CrossRefGoogle ScholarPubMed
Ferguson, SC, Blane, A, Wardlaw, J et al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 2005;28:1431–7.CrossRefGoogle ScholarPubMed
Strudwick, SK, Carne, C, Gardner, J, et al. Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia. J Pediatr 2005;147:680–5.CrossRefGoogle ScholarPubMed
Desrocher, M, Rovet, J. Neurocognitive correlates of Type 1 diabetes mellitus in childhood. Child Neuropsychol 2004;10:36–52.CrossRefGoogle ScholarPubMed
Perantie, DC, Wu, J, Koller, JM, et al. Diabetes Care 2007;30:2331–7.CrossRef
Brands, AM, Biessels, GJ, DeHaan, EH, et al. The effects of type 1 diabetes on cognitive performance; a meta-analysis. Diabetes Care 2005;28:726–35.CrossRefGoogle ScholarPubMed
Musen, G, Lyoo, IK, Sparks, CR, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006;55:326–33.CrossRefGoogle ScholarPubMed
Ferguson, SC, Blane, A, Perros, P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy preceding severe hypoglycemia. Diabetes 2003;52:149–56.CrossRefGoogle ScholarPubMed
Brands, AMA, Kessels, RPC, Hoogma, RPLM, et al. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 2006;55:1800–6.CrossRefGoogle ScholarPubMed
,The Diabetes Control and Complications Trial Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842–52.CrossRefGoogle Scholar
Berger, B, Stenstrom, G, Sundkvist, G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 1999;22:773–8.CrossRefGoogle Scholar
Hedley, AA, Ogden, CL, Johnson, CL, et al. Prevalence of overweight and obesity among US children, adolescents and adults, 1999–2002. J Am Med Assoc 2004;291:2847–50.CrossRefGoogle Scholar
Kaufman, F. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab 2002;15:737–44.CrossRefGoogle ScholarPubMed
Peterson, K, Silverstein, J, Kaufman, F, et al. Management of type 2 diabetes in youth: an update. Am Fam Physician 2007;76:658–64.Google ScholarPubMed
Awad, N, Gagnon, M, Messier, C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exper Neuropsychol 2004;26:1044–80.CrossRefGoogle ScholarPubMed
Brands, AM, Biessels, GJ, Kappelle, LJ, et al. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 2007;23:343–50.CrossRefGoogle ScholarPubMed
Ryan, CM, Geckle, MO. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab Res 2000;16:308–15.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Peila, R, Rodriguez, BL, Launer, LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies – the Honolulu-Asia aging study. Diabetes 2002;51:1256–62.CrossRefGoogle ScholarPubMed
Luchsinger, JA, Reitz, C, Patel, B, et al. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007;64:570–75.CrossRefGoogle ScholarPubMed
Merke, DP, Giedd, JN, Keil, MF, et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005;90:2531–6.CrossRefGoogle ScholarPubMed
Starkman, MN, Giordani, B, Gebarski, SS, et al. Improvement in learning associated with increase in hippocampal formation volume. Biol Psychiat 2003;53:233–8.CrossRefGoogle ScholarPubMed
Hook, JN, Giordani, B, Schteingardt, , et al. Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease. J Int Neuropsychological Soc 2007;13:21–9.CrossRefGoogle ScholarPubMed
Lee, BK, Glass, TA, McAtee, MJ, et al. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatr 2007;64:810–18.CrossRefGoogle ScholarPubMed
Anglin, RE, Rosebush, PI, Mazurek, MF. The neuropsychiatric profile of Addison's disease: Revisiting a forgotten phenomenon. J Neuropsych Clin N 2006;18:450–9.CrossRefGoogle ScholarPubMed
Kelso, WM, Nicholls, MER, Warne, GL, et al. Cerebral lateralization and cognitive functioning in patients with congenital adrenal hyperplasia. Neuropsychology 2000;14:370–8.CrossRefGoogle ScholarPubMed
Plante, E, Boliek, C, Binkiewicz, A, et al. Elevated androgen, brain development and language/learning disabilities in children with congenital adrenal hyperlplasia. Dev Med Child Neurol 1996;38:423–37.CrossRefGoogle Scholar
Johannsen, TH, Ripa, CPL, Reinisch, JM, et al. Impaired cognitive function in women with congenital adrenal hyperpasia. J Clin Endocrinol Metab 2006;91:1376–81.CrossRefGoogle Scholar
Imperato-McGinley, J, Pichardo, M, Gautier, T, et al. Cognitive abilities in androgen-insensitive subjects: Comparison with control males and females from the same kindred. Clin Endocrinol 1991;34:341–7.CrossRefGoogle ScholarPubMed
Knickmeyer, R, Baron-Cohen, S, Fane, BA, et al. Androgens and autistic traits: a study of individuals with congenital adrenal hyperplasia. Horm Behav 2006;50:148–53.CrossRefGoogle ScholarPubMed
Geschwind, N, Galaburda, AM. Cerebral Lateralization: Biological Mechanisms, Associations and Pathology. Cambridge, MA: MIT Press; 1987.Google Scholar
Hooven, CK, Chabris, CF, Ellsion, PT, et al. The relationship of male testosterone to components of mental rotation. Neuropsychologia 2004;42:782–90.CrossRefGoogle ScholarPubMed
Driscoll, I, Resnick, SM. Testosterone and cognition in normal aging and Alzheimer's disease: An update. Curr Alzheimer Res 2007;4:33–45.CrossRefGoogle ScholarPubMed
Yaffe, K, Lui, L-Y, Zmuda, J, Cauley, J. Sex hormones and cognitive function in older men. J Am Geriatrics Soc 2002;50:707–12.CrossRefGoogle ScholarPubMed
Moffat, SD. Effects of testosterone on cognitive and brain aging in elderly men. Ann N Y Acad Sci 2005;1055:80–92.CrossRefGoogle ScholarPubMed
Hogervorst, E, Williams, J, Budge, M, et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett 2001;22:163–8.Google ScholarPubMed
Burkhardt, MS, Foster, JK, Clarnette, RM, et al. Interaction between testosterone and epsilon 4 status on cognition in healthy older men. J Clin Endocrinol Metab 2006;91:1168–72.CrossRefGoogle Scholar
Hodes, GE, Shors, TJ. Distinctive stress effects on learning during puberty. Horm Behav 2005;48:163–71.CrossRefGoogle ScholarPubMed
Arnsten, AF, Shansky, RM. Adolescence: vulnerable period for stress-induced prefrontal cortical function? Introduction to part IV. Ann N Y Acad Sci 2004;1021:143–7.CrossRefGoogle ScholarPubMed
Dorn, LD, Hitt, SF, Rotenstein, D. Biopsychological and cognitive difference in children with premature vs on-time adrenarche. Arch Pediatr Adolesc Med 1999;153:137–46.CrossRefGoogle Scholar
Herlitz, A, Thilers, P, Habib, R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause 2007;14:425–31.CrossRefGoogle ScholarPubMed
Joffe, H, Hall, JE, Gurber, S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006;13:411–22.CrossRefGoogle ScholarPubMed
Rapp, SR, Espeland, MA, Shumaker, SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J Am Med Assoc 2003;28:2663–72.CrossRefGoogle Scholar
,Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2002;288:321–33.CrossRefGoogle Scholar
Rossouw, JE, Prentice, RL, Manson, JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc 2007;297:1465–77.CrossRefGoogle ScholarPubMed
MacLennan, AH, Henderson, VW, Paine, BJ, et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 2006;13:28–36.CrossRefGoogle ScholarPubMed
Hogervorst, E, Yaffe, K, Richards, M, et al. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Db Syst Rev 2002;3:CD003122.CrossRefGoogle Scholar
Jorm, AF, Korten, AE, Henderson, AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;76:475–9.CrossRefGoogle ScholarPubMed
Paganini-Hill, A, Henderson, VW. Estrogen deficiency and risk of Alzheimer disease in women. Am J Epidemiol 1994;140:256–61.CrossRefGoogle ScholarPubMed
Kawas, C, Resnick, S, Morrison, A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal study of Aging. Neurol 1997;48:1517–21.CrossRefGoogle ScholarPubMed
Shumaker, SA, Legault, C, Rapp, SR, et al. for the Women's Health Initiative Memory Study. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. J Am Med Assoc 2003;20:2651–62.CrossRefGoogle Scholar
Falleti, MG, Maruff, P, Burman, P, et al. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 2006;31:681–91.CrossRefGoogle ScholarPubMed
Vitiello, MV, Moe, KE, Merriam, GR, et al. Growth hormone releasing hormone improves the cognition of healthy older adults. Neurobiol Aging 2006;27:318–23.CrossRefGoogle ScholarPubMed
Singer, C, Tractenberg, RE, Kaye, J, et al. for the Alzheimer's Disease Cooperative Study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003;26:893–901.CrossRefGoogle ScholarPubMed
Jansen, SL, Forbes, DA, Duncan, V, et al. Melatonin for cognitive impairment. Cochrane Db Syst Rev 2006;25:CD003802.Google Scholar
Netley, C, Rovet, J. Verbal deficits in children with 47, XXY and 47, XXX karyotypes: A descriptive and experimental study. Brain Cogn 1982;17:58–72.Google ScholarPubMed
Rovet, J, Netley, C, Bailey, J, et al. Intelligence and achievement in children with extra X aneuoploidy: a longitudinal perspective. Am J Med Genet 1995;60:356–63.CrossRefGoogle Scholar
Rovet, J. The cognitive and neuropsychological characteristics of females with Turner syndrome. In Berch, DB, Bender, BD, eds. Sex Chromosome Abnormalities and Human Behavior. Boulder, CO: Westview Press; 1990: 38–77.Google Scholar
Rovet, J. Turner syndrome: a review of genetic and hormonal influences on neuropsychological functioning. Child Neuropsychol 2004;4:262–79.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×